Advertisement
Canada markets closed

  • S&P/TSX

    22,259.16
    -31.46 (-0.14%)
     

  • S&P 500

    5,187.67
    -0.03 (-0.00%)
     

  • DOW

    39,056.39
    +172.13 (+0.44%)
     

  • CAD/USD

    0.7288
    +0.0002 (+0.02%)
     

  • CRUDE OIL

    79.15
    +0.16 (+0.20%)
     

  • Bitcoin CAD

    84,100.94
    -2,129.28 (-2.47%)
     

  • CMC Crypto 200

    1,307.32
    +12.65 (+0.98%)
     

  • GOLD FUTURES

    2,317.10
    -5.20 (-0.22%)
     

  • RUSSELL 2000

    2,055.14
    -9.51 (-0.46%)
     

  • 10-Yr Bond

    4.4920
    +0.0290 (+0.65%)
     

  • NASDAQ futures

    18,166.00
    -20.50 (-0.11%)
     

  • VOLATILITY

    13.00
    -0.23 (-1.74%)
     

  • FTSE

    8,354.05
    +40.38 (+0.49%)
     

  • NIKKEI 225

    38,202.37
    -632.73 (-1.63%)
     

  • CAD/EUR

    0.6776
    +0.0005 (+0.07%)
     

Coherus BioSciences to Report Second Quarter 2021 Financial Results on August 5th

Coherus BioSciences, Inc.
·1 min read

REDWOOD CITY, Calif., July 26, 2021 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (“Coherus”, Nasdaq: CHRS), today announced that its second quarter 2021 financial results will be released after market close on Thursday, August 5, 2021. Starting at 5 p.m. ET, Coherus’ management team will host a conference call and webcast to discuss financial results and provide a general business update.

After releasing second quarter financial results, the Company will post them on the Coherus website at https://investors.coherus.com.

Conference Call Information

When: Thursday, August 5, 2021 starting at 5:00 p.m. ET

ADVERTISEMENT

Dial-in: (844) 452-6826 (Toll-Free U.S. and Canada) or (765) 507-2587 (International)

Conference ID: 9146617

Webcast: https://investors.coherus.com/upcoming-events

Please dial-in 15 minutes early to ensure a timely connection to the call.

About Coherus BioSciences
Coherus is a commercial stage biopharmaceutical company with the mission to increase access to cost-effective medicines that can have a major impact on patients’ lives and to deliver significant savings to the health care system. For additional information, please visit www.coherus.com.

CONTACT: Contact Information: Investor Contact: McDavid Stilwell, CFO Coherus BioSciences, Inc. IR@coherus.com